Jur Strobos MD

Dr. Jur Strobos is a partner in the Washington, DC office. Jur provides legal, regulatory, and policy advice to life science companies regulated by the US Food and Drug Administration (FDA). Jur was a regulatory and policy official for FDA’s Commissioner and a credentialed federal law enforcement officer.

During his prior practice he had the opportunity to serve part-time as a senior executive managing legal, regulatory, and product development at five start-ups and full-time as VP Clinical and Regulatory Affairs at a NYSE-traded company.

His work resulted in approval of 5 new drugs, 2 premarket-approved medical devices, a cell therapy and a biological product. His work included strategic policy and evaluation of in-licensing or sale of products including acquisition and merger.

From 2010 to 2017, Jur taught a graduate level course on drug development at the University of California Berkeley. He has numerous publications on drug development, clinical trial design, statistics, and pharmacovigilance.

Jur has practiced FDA law (food, cosmetics, drugs, biological products, drugs, controlled substances, alcohol and tobacco) for 20 years before joining Baker McKenzie in 2016. Jur supports mergers and acquisitions, licensing, recalls and compliance to creative solutions to regulatory impediments that could delay marketing authorization on both a US and EU basis.

He assists with inspectional readiness, compliance agreements, delegation subcontracts with clinical sites, research and manufacturing organizations, Sunshine Act, False Claims Act, promotion, and food safety, among others.

Education:

• Johns Hopkins University (B.A. cum laude)
• University of Pennsylvania (J.D.)
• University of Chicago (M.D.)

Admissions:

• District of Columbia
• California

Corporate Responsibility:

Jur worked for the Bill and Melinda Gates Foundation from 2010-2011 organizing a consortium of academic, government, patient, and industry leaders to secure the approval of tenofovir for the pre-exposure prophylaxis of HIV infection. He has served on the Board of Directors of a school for disabled children.